Iron depositions, one of the non-transferrin-bound iron (NTBI), are frequently observed for the patients with thalassemia, hemochromatosis and other iron-overloading disorders. In this article, we have pointed out that zinc(II) ion and hydrogen peroxide play a critical role in the formation of the iron deposition, and that the formation of iron deposition by zinc(II) ion should be one of the important method to protect the oxidative stress by water-soluble NTBI. This implies that the zinc(II) ions contribute to depress the oxidative stress by NTBI.
, the structure of this complex being illustrated in Figure 3 . Figure 1 . Structure of model compound of hemosiderin with H 3 (hida). In the center circle (Fe, black: oxygen, red) , seven iron(III) ions are surrounded by ten oxo anions forming the aggregation of eight di--oxo-diiron(III) species Figure 2 . The structures of the ligands cited in this paper Figure 3 clearly indicates that the exclusion of the oxo anions around the iron(III) ion leads to the formation of water-soluble species, which again supports that oxo anions are closely related with the formation of iron deposition. Similar facts are also observed for the case of H 2 (ida) chelate (see Figure 2 ). These facts are demonstrating that there is an equilibrium between the water-insoluble and water-soluble iron(III) species in the solution (see Scheme I), which is controlled by the concentrations of oxo-anion and chelates. Both the water-insoluble and water-soluble species are called as NTBI, but NTBI that play an important role in iron induced oxidative stress should be water-soluble ones (Nishida, 2009 Vol. 4, No. 6; 2012 Scheme II
Zinc(II) Species Act as OH --Transporter to Give Iron Deposition
We have found that deposition of the iron(III) hydroxide occurs readily on the aggregates of amyloid beta-peptide (A (1-40)) when zinc(II) chloride solution is added to the solution (pH=7.4) containing iron(III) compounds with (nta), (edda), and other amino acid derivatives, and A(1-40) . We have observed that the similar iron deposition has occurred on several proteins such as albumin or transferrin, indicating that iron deposition by zinc(II) ions are not specific for the amyloid proteins.
It seems quite likely that the formation of iron deposition observed above proceeds according to the Scheme III: zinc(II) complex which contains hydroxide ion (OH -) approaches to the protein, where the iron(III) complexes bind with the protein through two-point interaction (Scheme III) (Nishida, Itoh, & Satoh, 2007) , and then the transfer of the hydroxide ion from the zinc(II) to the iron(III) ion occurs, to lead to the formation of di--oxo-iron(III) species, and finally to iron deposition as illustrated in Scheme II. In this reaction the zinc(II) ions are operating as OH --transporter to give di--oxo-iron(III) species on the protein. Since the total zinc(II) concentration is relatively reduced compared with that of normal cases, and massive iron deposition are observed in the brain and on several organs such as kidney or spleen of the aceruplasminemia patients (Yoshida et al., 2000) , it seems reasonable to assume that zinc(II) ions play an important role on the formation of the iron deposition in the aceruplasminemia patients. Since the formation of the iron deposition means the deletion of toxic NTBI from the plasma, we can consider that zinc(II) ions act as an antioxidant in the patients of several neurodegenerative disorders. Thus, the amyloid deposition which frequently observed for the Alzheimer's patients, may be due to one of the antioxidative function by zinc(II) ion, which is consistent with the fact that amyloid deposits generally contain much quantities of iron(III) and zinc(II) ions (Bush, 2003) .
Scheme III

Transferrin Rigorously Distinguishes and Recognizes the Structure of the Iorn(III) Chelates
Transferrins are group of iron-binding proteins, that include serum transferrin, lactoferrin and ovotransferrin; they are all glycoproteins that have a molecular mass of about 80 kDa, and bind two Fe 3+ per molecule with high affinity. Serum transferrin has a specific role as an iron transporter, delivering the bound iron to target cells via receptor-mediated endocytosis. But, the detailed mechanism of up-take of iron-ion from the solution by apo-transferrin remains unclear at present. Vol. 4, No. 6; 2012 
